未有的考验.......................................................................................................19
§3.2.3 卫生体制改革艰难,钳制药品零售市场发力....................................19
§3.2.4 医保、金融与药品零售市场的对接存在障碍....................................19
§3.2.5 医药政策的不系统性,将严重束缚行业的发展................................20
§3.2.6 产权、隶属关系条块分割以及由此产生的地方保护主义使连锁业范
围受到局限.......................................................................................................21
§3.2.7 恶性竞争影响行业整体发展................................................................21
第四章 我国医药零售连锁经营的内部优劣势分析...................................................23
§4.1 竞争优势(strength).....................................................................................23
§4.1.1 规模优势................................................................................................23
§4.1.2 渠道网络优势........................................................................................23
§4.1.3 品牌优势................................................................................................23
§4.1.4 商品经营风险小、可复制性强............................................................23
§4.1.5 员工素质优势........................................................................................23
§4.1.6 品种优势...............................................................................................24
§4.2 劣势(weakness).......................................................................................... 25
§4.2.1 我国医药零售连锁业分布散,规模不集中,资金缺乏....................25
§4.2.2 经营人才极度匮乏................................................................................25
§4.2.3 物流配送落后........................................................................................25
§4.2.4 营销策略单一,管理滞后,成本居高不下........................................26
§4.2.5 缺乏消费者研究....................................................................................27
§4.2.6 没有成熟的赢利模式,赢利能力差....................................................27
第五章 我国医药零售连锁经营的运作策略...............................................................29
§5.1 融资,扩大连锁经营的规模(SO) .....................................................................29
§5.2 树立药店强势服务品牌(SO) ..........................................................................30
§5.3 创新赢利模式(WO) ........................................................................................ 31
§5.3.1 总代理盈利模式、自有品牌盈利模式、PTO 盈利模式................... 31
§5.3.2 数据库盈利模式、品类管理盈利模式................................................31
§5.4 优化连锁药店管理流程(WO)...................................................................31
§5.5 打造我国药品零售业的核心竞争力(WO) .................................................... 32
§5.5.1 实施产品的差异化战略,提供切合消费者实际需求的产品组合.......32
§5.5.2 采用成本领先战略................................................................................33
§5.6 建立高效、准确、低成本的物流体系(WO) ................................................ 35
§5.7 人才奇缺的解决对策(WO) ........................................................................... 35